New Blue Book Reveals Myopia Crisis: Children at Risk
Baca dalam 60 detik
- The Blue Book synthesizes global research and Chinese clinical data to forecast a 60% prevalence rate among adolescents by 2030.
- Key drivers include increased screen time, reduced outdoor activity, and genetic factors.
- Without intervention, the economic burden could exceed $200 billion annually in China alone.
The Blue Book synthesizes global research and Chinese clinical data to forecast a 60% prevalence rate among adolescents by 2030. Key drivers include increased screen time, reduced outdoor activity, and genetic factors. Without intervention, the economic burden could exceed $200 billion annually in China alone.
ShiJing Medical's proprietary AI-driven screening tools identified early-onset myopia in children as young as six. The report emphasizes that outdoor time of at least two hours daily can reduce incidence by 30%. Digital therapeutics and orthokeratology lenses emerge as top-tier interventions.
Strategic partnerships between tech firms and healthcare providers are accelerating personalized treatment plans. The Blue Book calls for national screening programs and government subsidies for corrective devices. China's 'Healthy China 2030' initiative aligns with these recommendations, but execution gaps persist.
Power Move: The Blue Book is a wake-up call: myopia management is no longer optional—it's a public health priority. Investors should watch ShiJing Medical's screening tech and digital therapeutics startups. The race to capture the myopia management market just intensified.
This article was edited with AI assistance for readability. Read original here.
